Form 4 filings across 3 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$25.1M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 7 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 24 most recent Form 4 transactions.
| Mar 2 | NAMS | NewAmsterdam Pharma Co… | MEXER◆ | 443,707 | — | — | — | Open the original filing on SEC.gov |
| Mar 2 | NAMS | NewAmsterdam Pharma Co… | SSELL | 443,707 | $33.25 | $14.8M | -71.8% | Open the original filing on SEC.gov |
| Mar 2 | NAMS | NewAmsterdam Pharma Co… | MEXER | 443,707 | — | — | +254.8% | Open the original filing on SEC.gov |
| Feb 26 | NAMS | NewAmsterdam Pharma Co… | MEXER◷◆ | 183,332 | — | — | — | Open the original filing on SEC.gov |
| Feb 26 | NAMS | NewAmsterdam Pharma Co… | SSELL◷ | 17,924 | $34.44 | $617.3K | -9.3% | Open the original filing on SEC.gov |
| Feb 26 | NAMS | NewAmsterdam Pharma Co… | SSELL◷ | 165,408 | $33.63 | $5.6M | -25.7% | Open the original filing on SEC.gov |
| Feb 26 | NAMS | NewAmsterdam Pharma Co… | MEXER◷ | 183,332 | — | — | +39.9% | Open the original filing on SEC.gov |
| Feb 25 | NAMS | NewAmsterdam Pharma Co… | MEXER◷◆ | 58,253 | — | — | — | Open the original filing on SEC.gov |
| Feb 25 | NAMS | NewAmsterdam Pharma Co… | SSELL◷ | 1,300 | $36.68 | $47.7K | -0.3% | Open the original filing on SEC.gov |
| Feb 25 | NAMS | NewAmsterdam Pharma Co… | SSELL◷ | 10,436 | $35.96 | $375.3K | -2.2% | Open the original filing on SEC.gov |
| Feb 25 | NAMS | NewAmsterdam Pharma Co… | SSELL◷ | 46,517 | $35.11 | $1.6M | -9.0% | Open the original filing on SEC.gov |
| Feb 25 | NAMS | NewAmsterdam Pharma Co… | MEXER◷ | 58,253 | — | — | +12.7% | Open the original filing on SEC.gov |
| Feb 24 | NAMS | NewAmsterdam Pharma Co… | MEXER◷◆ | 64,708 | — | — | — | Open the original filing on SEC.gov |
| Feb 24 | NAMS | NewAmsterdam Pharma Co… | SSELL◷ | 3,161 | $36.46 | $115.3K | -0.7% | Open the original filing on SEC.gov |
| Feb 24 | NAMS | NewAmsterdam Pharma Co… | SSELL◷ | 61,547 | $36.13 | $2.2M | -11.7% | Open the original filing on SEC.gov |
| Feb 24 | NAMS | NewAmsterdam Pharma Co… | MEXER◷ | 64,708 | — | — | +14.1% | Open the original filing on SEC.gov |
| Jan 9 | TENX | Tenax Therapeutics, INC. | AGRANT◆ | 30,000 | — | — | — | Open the original filing on SEC.gov |
| Jan 7 | NAMS | NewAmsterdam Pharma Co… | AGRANT◷◆ | 364,000 | — | — | — | Open the original filing on SEC.gov |
| Jan 7 | NAMS | NewAmsterdam Pharma Co… | AGRANT◷ | 81,000 | — | — | +21.4% | Open the original filing on SEC.gov |
| Jan 7 | NAMS | NewAmsterdam Pharma Co… | SSELL◷ | 11,582 | — | — | -3.0% | Open the original filing on SEC.gov |
| Jul 1, 2025 | TENX | Tenax Therapeutics, INC. | AGRANT◆ | 80,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 5, 2025 | BIOA | BioAge Labs, Inc. | AGRANT◆ | 22,000 | — | — | — | Open the original filing on SEC.gov |